01-29-2021, 11:40 AM
(01-29-2021, 10:01 AM)EricL Wrote:(01-29-2021, 09:57 AM)divmenow Wrote: I'm out of JNJ. It had a nice run but that vaccine news was not good at all
JNJ had said they were going to sell the vaccine for cost anyways. Good or bad, I don't think it has much impact on the company's profits.
Also, I don't think the vaccine news is nearly as bad as the market is saying. 85% effective in preventing severe disease and 100% effective against COVID-related hospitalization and death.
Quote:The vaccine candidate was 85 percent effective in preventing severe disease across all regions studied,i 28 days after vaccination in all adults 18 years and older. Efficacy against severe disease increased over time with no cases in vaccinated participants reported after day 49.
The Janssen COVID-19 vaccine candidate demonstrated complete protection against COVID-related hospitalization and death, 28 days post-vaccination. There was a clear effect of the vaccine on COVID-19 cases requiring medical intervention (hospitalization, ICU admission, mechanical ventilation, extracorporeal membrane oxygenation (ECMO)), with no reported cases among participants who had received the Janssen COVID-19 vaccine, 28 days post-vaccination.
The economy can open up completely with those results. Single-shot dose with normal vaccine storage requirements as well.
I stand by my prediction that the economy will be pretty much open by this summer.